Racial and Ethnic Differences in Initiation and Discontinuation of Antiarrhythmic Medications in Management of Atrial Fibrillation

Background: Atrial fibrillation (AF) is associated with considerable morbidity and mortality.Timely management and treatment are critical in alleviating AF disease burden.There is significant heterogeneity in patterns of AF care.It is unclear whether there are racial and ethnic differences in treatment of AF following antiarrhythmic drug (AAD) prescription.Methods: Using the Optum Clinformatics Data Mart-Socioeconomic Status database from January, 2009, through March, 2022, multivariable logistic regression techniques were used to examine the impact of race and ethnicity on rate of AAD initiation, as well as receipt of catheter ablation within two years of initiation.We compared AAD discontinuation rate by race and ethnicity groups using Cox regression models.Log-rank analyses were used to examine the rate of AF-related hospitalization.Results: Among 143,281 patients identified with newly diagnosed AF, 30,019 patients (21%) were initiated on an AAD within 90 days.Patients identified as Non-Hispanic Black (NHB) were significantly less likely to receive an AAD compared to Non-Hispanic White patients (NHW) (Odds Ratio OR 0.90, 95% confidence interval CI 0.85-0.94).Compared to NHW, Hispanic (Hazard Ratio HR 1.08, 95% CI 1.02-1.14)and Asian patients (HR 1.17, 95% CI 1.06-1.29)have a higher rate of AAD discontinuation.Following AAD initiation, NHB patients were significantly more likely to have an AF-related hospitalization (p < 0.01).However, NHB patients were significantly less likely to receive ablation compared to NHW (HR 0.83, 95% CI 0.70-0.97),and less likely to change AAD (p < 0.01).Conclusion: Patients identified as NHB are 10% less likely to receive an AAD for treatment of newly diagnosed AF.Compared to NHW, Hispanic and Asian patients were more likely to discontinue AAD treatment.Once initiated on an AAD, NHB patients were significantly more likely to have an AF -related hospitalization, but were 17% less likely to receive ablation compared to NHW patients.The etiology of, and interventions to reduce, these disparities require further investigation.